Efectividad de anticuerpos antitransglutaminasa IgA en la evaluación de la dieta sin gluten en pacientes celiacos. Evolución de la hipertransaminasemia y ferropenia

  1. M.J. Llorente
  2. M.J. Fernández Aceñero
  3. M. F. Sebastián Bonel
  4. S. Villanueva
  5. L. Criado Gómez
  6. E. Aguirregoicoa
Journal:
Revista del laboratorio clínico

ISSN: 1888-4008

Year of publication: 2008

Volume: 1

Issue: 3

Pages: 94-99

Type: Article

DOI: 10.1016/J.LABCLI.2008.09.003 DIALNET GOOGLE SCHOLAR

More publications in: Revista del laboratorio clínico

Abstract

Objective To analyze the validity of antitransglutaminase antibodies (tTGA) as a serological marker of response to the gluten-free diet (GFD) in celiac patients and to determine the outcome of hypertransaminasemia (HT) and ferropenia found at the time of diagnosis. Material and methods We have retrospectively analyzed the data from 172 patients with celiac disease (CD) (141 children and 31 adults) following a GFD. We have collected clinical and diet information and also histological, biochemical and serological data. The tTGA was measured with a human recombinant antibody. Results After a median follow-up time of 1.5 years in GFD, 114 (81%) of the children had normal levels of tTGA, 17 (12%) showed values in the “grey zone” and only 10 (7%) had elevated levels of this marker. This contrasts with the figures found in adults, corresponding to 15 (48.3%), 11 (33.5%) and 5 (17.2%), respectively. In our series we have performed 27 intestinal biopsies during follow-up (26 children and 1 adult). The concordance rate between the results of this biopsy and the tTGA determination was high, with a Kappa Index=0.898. We have detected dietary transgressions in 7 patients (4 occasional and 3 frequently) and 6 of these 7 patients showed high levels of tTGA. The GFD was correctly followed by children according to the international recommendations, but only 40% of the adults followed the GFD adequately. In both populations we have found a significant decrease in HT and normalization of the ferropenia found at diagnosis (P<0.001). Conclusions tTGA is a useful indirect marker for evaluation of GFD in a pediatric population, with a high concordance between serum levels of the marker and histological findings in the intestinal biopsy. However, tTGA cannot substitute biopsy in cases of diet transgressions or unfavourable clinical evolution. In our environment it is still essential to increase the awareness of the adult population regarding the importance of diet in CD and also of the serious complications associated with untreated disease.